Hypoxia inducible factor: a potential prognostic biomarker in oral squamous cell carcinoma
- 209 Downloads
Oral squamous cell carcinoma (OSCC) is the most common oral cancer. Hypoxia inducible factor (HIF) is involved in many malignant tumors’ growth and metastasis and upregulated by hypoxia, including oral cancer. Many studies have studied about the prognostic value of HIF expression in OSCC; however, they do not get the consistent results. Therefore, this study explored the correlation between the HIF expression and the prognosis of OSCC. It conducted a meta-analysis of relevant publications searched in the Web of Science, PubMed, and ISI Web of Knowledge databases. Totally, this study identified 12 relevant articles reporting a total of 1112 patients. This analysis revealed a significant association between increased risk of mortality (RR = 1.20; 95 % CI 0.74–1.95; I 2 85.4 %) and overexpression of HIFs. Furthermore, different HIF isoforms were associated with overall survival [HIF-1α (RR = 1.18; 95 % CI 0.66–2.11; I 2 87.2 %) and HIF-2α (RR = 1.40; 95 % CI 0.93–2.09; I2 0.0 %)]. These results show that overexpression of HIFs, regardless of whether the HIF-1α or HIF-2α isoforms are overexpressed is significantly associated with increased risk of mortality in OSCC patients. In this study, the funnel is symmetric, suggesting existed no publication bias.
KeywordsHypoxia inducible factor Prognostic value Biomarker Oral squamous cell carcinoma
This study was financially supported by National Natural Science Foundation of China (81302351), Jiangsu Provincial Natural Science Foundation (BK 20131080), Distinguished young investigator project of Nanjing (JQX14010).
Compliance with ethical standards
Conflicts of interest
- 3.Kimple AJ, Welch CM, Zevallos JP, Patel SN. Oral cavity squamous cell carcinoma—an overview. Oral health Dent Manage. 2014;13(3):877–82.Google Scholar
- 13.Lin PY, Yu CH, Wang JT, Chen HH, Cheng SJ, Kuo MY, et al. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. J Oral Pathol Med Off Pub Int Assoc Oral Pathol Am Acad Oral Pathol. 2008;37(1):18–25. doi: 10.1111/j.1600-0714.2007.00571.x.Google Scholar
- 14.Zhu GQ, Tang YL, Li L, Zheng M, Jiang J, Li XY, et al. Hypoxia inducible factor 1 alpha and hypoxia inducible factor 2 alpha play distinct and functionally overlapping roles in oral squamous cell carcinoma. Clin Cancer Res Off J Am Assoc Cancer Res. 2010;16(19):4732–41. doi: 10.1158/1078-0432.ccr-10-1408.CrossRefGoogle Scholar
- 15.Eckert AW, Lautner MH, Schutze A, Bolte K, Bache M, Kappler M, et al. Co-expression of Hif1alpha and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2010;39(4):313–7. doi: 10.1111/j.1600-0714.2009.00829.x.Google Scholar
- 16.Eckert AW, Lautner MH, Schutze A, Taubert H, Schubert J, Bilkenroth U. Coexpression of hypoxia-inducible factor-1alpha and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients. Histopathology. 2011;58(7):1136–47. doi: 10.1111/j.1365-2559.2011.03806.x.CrossRefPubMedGoogle Scholar
- 17.Liang X, Zheng M, Jiang J, Zhu G, Yang J, Tang Y. Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma. Oral Oncol. 2011;47(2):92–7. doi: 10.1016/j.oraloncology.2010.11.014.CrossRefPubMedGoogle Scholar
- 19.Mendes SO, dos Santos M, Peterle GT, Maia Lde L, Stur E, Agostini LP, et al. HIF-1alpha expression profile in intratumoral and peritumoral inflammatory cells as a prognostic marker for squamous cell carcinoma of the oral cavity. PLoS One. 2014;9(1):e84923. doi: 10.1371/journal.pone.0084923.CrossRefPubMedPubMedCentralGoogle Scholar
- 26.Raval RR, Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL, et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol. 2005;25(13):5675–86. doi: 10.1128/mcb.25.13.5675-5686.2005.CrossRefPubMedPubMedCentralGoogle Scholar
- 28.Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H, et al. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell. 2006;10(5):413–23. doi: 10.1016/j.ccr.2006.08.026.CrossRefPubMedGoogle Scholar